WALTHAM, Mass.--(BUSINESS WIRE)--
NeuroMetrix,
Inc. (Nasdaq: NURO), an innovative health care company that develops
wearable medical technology and point-of-care tests to help patients and
physicians manage chronic pain, nerve diseases, and sleep disorders,
today announced that Shai N. Gozani M.D., Ph.D., President and Chief
Executive Officer, is scheduled to speak at the Rodman & Renshaw Annual
Global Investment Conference at the New York Palace Hotel, New York, NY
on September 8-10, 2014. Dr. Gozani intends to provide an update on the
Company's business activities including the SENSUS® Pain
Management System for chronic pain and sleep, and the Company's emerging
consumer healthcare initiative.
NeuroMetrix's presentation is scheduled for Tuesday, September 9, 2014
at 9:10 am (Eastern Daylight Time) in the Kennedy II Salon Room, 4th
Floor. A live audio webcast will be available on the investor relations
section of the corporate website - http://www.NeuroMetrix.com.
This webcast will be archived after the live event.
About NeuroMetrix
NeuroMetrix is an innovative health-care company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. The Company has a major focus on diabetic neuropathies, which
affect over 50% of people with diabetes. If left untreated, diabetic
neuropathies trigger foot ulcers that may require amputation and cause
disabling chronic pain. The annual cost of diabetic neuropathies has
been estimated at $14 billion in the United States. The Company markets
the SENSUS® device for treating chronic pain, focusing on
physicians managing patients with neuropathic pain such as painful
diabetic neuropathy. The Company also markets DPNCheck®,
which is a rapid, accurate, and quantitative point-of-care test for
peripheral neuropathies such as diabetic neuropathy. This product is
used to detect neuropathies at an early stage and to guide treatment.
For more information, please visit http://www.NeuroMetrix.com.
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and
Chief Financial Officer
neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
News Provided by Acquire Media
